PDF icon Download PDF
Fortschr Neurol Psychiatr 2003; 71: 27-32
DOI: 10.1055/s-2003-40502
Originalarbeit
© Georg Thieme Verlag Stuttgart · New York

Die Bedeutung von Interneuronen bei affektiven und schizophrenen Erkrankungen

The Importance of Interneurons in Schizophrenic and Affective DisordersH.  Scherk1 , K.  Vogeley2 , P.  Falkai1
  • 1Universitätskliniken des Saarlandes · Nervenklinik und Poliklinik · Psychiatrie und Psychotherapie, Homburg (Leiter: Prof. Dr. P. Falkai)
  • 2Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Bonn
Further Information

Publication History

Publication Date:
08 July 2003 (online)

Also available ateRef
   Permissions and Reprints
Preview

Zusammenfassung

Schizophrene und affektive Psychosen weisen pathomorphologische Veränderungen mit frontotemporalem Schwerpunkt auf. Die im präfrontalen Kortex beobachtete Volumenreduktion bei schizophrenen Patienten ist bei relativ erhöhter Zelldichte auf eine Neuropilreduktion zurückzuführen. Zusammen mit einer verminderten Expression synaptischer Proteine ist dies ein Hinweis auf eine gestörte neuronale Konnektivität. Für eine intakte Konnektivität sind aber auch Interneurone von großer Bedeutung. Bei schizophrenen und affektiven Psychosen sind GABA-erge Interneurone vermindert. Eine gestörte Verschaltung des glutamatergen, GABA-ergen und dopaminergen Systems könnten in Kombination mit der reduzierten Zahl von Interneuronen das Korrelat für ein defizientes neuronales Netzwerk sein, welches unter exogenen Faktoren psychotische Symptome generiert. Reelin bzw. sein Pathway stellen Kandidatenmoleküle dar, deren Fehlregulation wesentliche Merkmale des dysfunktionellen Netzwerkes bei der Schizophrenie erklären.

Abstract

In brains of patients with schizophrenic and affective disorders pathomorphological changes have been shown focussing in frontal and temporal cortex. The volume reduction in prefrontal cortex of schizophrenic patients is hypothesized to be based on a reduction of neuropil. A decrease of synaptic proteins and a decrease of dendritic spines of pyramidal cells can additionally be the origin of disconnections of neurons. Affection of the glutamatergic, GABA-ergic and dopaminergic system and reduction of interneurons could be the correlate of a deficient neuronal network which might be combined with exogen factors generate psychotic symptoms. Reelin and associated proteins are candidate molecules. Their dysregulation might explain essential features of the dysfunctional network of schizophrenia.

Literatur

  • 1 Hopkins R, Lewis S. Structural imaging finding and macroscopic pathology. In: Harrison PJ, Roberts GW (Hrsg). The neuropathology of schizophrenia - Progress and Interpretation. Oxford: University Press 2000: 5-56
    Search in Google Scholar
  • 2 Vogeley K, Falkai P. The dysconnectivity hypothesis of schizophrenia.  Neurology Psychiatry Brain Research. 1998;  6 113-122
    PubMedSearch in Google Scholar
  • 3 Amaral D G. The anatomical organization of the central nervous system. In: Kandel ER, Schwartz JH, Jessel TM. Principles of neural science. New York, McGraw-Hill 2000: 317-336
    Search in Google Scholar
  • 4 Lewis D A. The organization of the cortical circuitry. In: Harrison PJ, Roberts GW (Hrsg). The neuropathology of schizophrenia - Progress and Interpretation Oxford: University Press 2000: 235-256
    Search in Google Scholar
  • 5 Soares J C, Mann J J. The anatomy of mood disorders - review of structural neuroimaging studies.  Biol Psychiatry. 1997;  41 86-106
    CrossrefPubMedSearch in Google Scholar
  • 6 Benes F M, Vincent S L, Todtenkopf M. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenics and bipolar subjects.  Biol Psychiatry. 2001;  50 395-406
    CrossrefPubMedSearch in Google Scholar
  • 7 Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells.  Biol Psychiatry. 2000;  48 766-777
    CrossrefPubMedSearch in Google Scholar
  • 8 McCarley R W, Wible C G, Frumin M, Hirayasu Y, Levitt J J, Fischer I A, Shenton M E. MRI anatomy of schizophrenia.  Biol Psychiatry. 1999;  45 1099-1119
    CrossrefPubMedSearch in Google Scholar
  • 9 Selemon L D, Rajkowska G, Goldman-Rakic P S. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17.  Arch Gen Psychiatry. 1995;  52 805-818
    PubMedSearch in Google Scholar
  • 10 Falkai P, Bogerts B. Cell loss in the hippocampus of schizophrenics.  Eur Arch Psych Neurol Sci. 1986;  236 154-161
    PubMedSearch in Google Scholar
  • 11 Benes F M, McSparren J, Bird E D, Vincent S L, SanGiovanni J P. Deficits in small interneurons in prefrontal and anterior cingulate cortex of schizophrenic and schizoaffective patients.  Arch Gen Psychiatry. 1991;  48 996-1001
    CrossrefPubMedSearch in Google Scholar
  • 12 Benes F M, Kwok S W, Vincent S L, Todtenkopf M S. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives.  Biol Psychiatry. 1998;  44 88-97
    CrossrefPubMedSearch in Google Scholar
  • 13 Akbarian S, Kim J J, Potkin S G, Hagman J O, Tafazzoli A, Bunney W E Jr, Jones E G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.  Arch Gen Psychiatry. 1995;  52 258-266
    CrossrefPubMedSearch in Google Scholar
  • 14 Rajkowska G, Selemon L D, Goldman-Rakic P S. Neuronal and glial soma size in the prefrontal cortex: a post-mortem study of schizophrenics and Huntington's disease.  Arch Gen Psychiatry. 1998;  55 215-224
    PubMedSearch in Google Scholar
  • 15 Selemon L D, Rajkowska G, Goldman-Rakic P S. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: Application of a 3-dimensional stereologic counting method.  J Comp Neurol. 1998;  392 402-412
    PubMedSearch in Google Scholar
  • 16 Selemon L D, Goldman-Rakic P S. The reduced neuropil hypothesis: A circuit based model of schizophrenia.  Biol Psychiatry. 1999;  45 17-25
    Search in Google Scholar
  • 17 Garey L J, Ong W Y, Patel T S, Kanani M, Davis A, Mortimer A M, Barnes T RE, Hirsch S R. Reduction dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia.  J Neurol Neurosurg Psychiatry. 1998;  65 446-453
    PubMedSearch in Google Scholar
  • 18 Glantz L A, Lewis D A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia.  Arch Gen Psychiatry. 2000;  57 65-73
    PubMedSearch in Google Scholar
  • 19 Honer W G, Young C, Falkai P. Synaptic pathology. In: Harrison PJ, Roberts GW (Hrsg). The neuropathology of schizophrenia - Progress and Interpretation. Oxford: University Press 2000: 105-136
    Search in Google Scholar
  • 20 Fatemi S H, Earle J A, Stary J M, Lee S, Sedgewick J. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia.  Neuroreport. 2001;  12 3257-3262
    PubMedSearch in Google Scholar
  • 21 Eastwood S L, Harrison P J. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins.  Brain Res Bull. 2001;  55 569-578
    CrossrefPubMedSearch in Google Scholar
  • 22 Benes F M. Emerging principles of altered neural circuitry in schizophrenia.  Brain Research Reviews. 2000;  31 251-269
    CrossrefPubMedSearch in Google Scholar
  • 23 Bird E D, Spokes E GS, Iversen L L. Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia.  Brain. 1979;  102 347-360
    PubMedSearch in Google Scholar
  • 24 Simpson M D, Slater P, Deakin J F, Ryoston M C, Skan W J. Reduced GABA uptake sites in the temporal lobe in schizophrenia.  Neurosci Lett. 1989;  107 211-215
    CrossrefPubMedSearch in Google Scholar
  • 25 Reynolds G P, Czudek C, Andrews H. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia.  Biol Psychiatry. 1990;  27 1038-1044
    CrossrefPubMedSearch in Google Scholar
  • 26 Beasley C L, Reynolds G P. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics.  Schizophr Res. 1996;  24 349-355
    PubMedSearch in Google Scholar
  • 27 Benes F M, Vincent S L, Alsterberg G, Bird E D, SanGiovanni J-P. Increased GABA receptor binding in supragranular layers of schizophrenic cingulate cortex.  J Neurosci. 1992;  12 924-929
    PubMedSearch in Google Scholar
  • 28 Benes F M, Vincent S, Marie A, Khan Y. Upregulation of GABA-A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects.  Neurosci. 1996;  75 1021-1031
    CrossrefPubMedSearch in Google Scholar
  • 29 Benes F M, Khan Y, Vincent S L, Wickramasinghe R. Differences in the subregional and cellular distribution of GABA-A receptor binding in the hippocampal formation of schizophrenic brain.  Synapse. 1996;  22 338-349
    CrossrefPubMedSearch in Google Scholar
  • 30 Woo T-U, Whitehead R E, Melchitzky D S, Lewis D A. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia.  Proc Natl Acad Sci USA. 1998;  95 5341-5346
    CrossrefPubMedSearch in Google Scholar
  • 31 Benes F M, Majocha R, Bird E D, Marotta C A. Increased vertical axon numbers in cingulate cortex of schizophrenics.  Arch Gen Psychiatry. 1987;  44 1017-1021
    PubMedSearch in Google Scholar
  • 32 Benes F M, Sorensen I, Vincent S L, Bird E D, Sathi M. Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain.  Cereb Kortex. 1992;  2 502-512
    PubMedSearch in Google Scholar
  • 33 Benes F M. Cortical pathology: a new generation of quantitative microscopic studies. In: Harrison PJ, Roberts GW (Hrsg). The neuropathology of schizophrenia - Progress and Interpretation. Oxford: University Press 2000: 81-104
    Search in Google Scholar
  • 34 Benes F M, Todtenkopf M S, Taylor J B. Differential distribution of tyrosine hyxdroxylase fibers on neuronal subtypes in layer II of anterior cingulate cortex of schizophrenic brain.  Synapse. 1997;  25 80-92
    CrossrefPubMedSearch in Google Scholar
  • 35 Benes F M, Todtenkopf M S, Logiotatos P, Williams M. Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain.  J Chem Neuroanat. 2000;  20 259 -269
    CrossrefPubMedSearch in Google Scholar
  • 36 Falkai P, Honer W G, David S, Bogerts B, Majtenyi C, Bayer T A. No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study.  Neuropathol Appl Neurobiol. 1999;  25 48-53
    Search in Google Scholar
  • 37 Guidotti A, Auta J, Davis J M, DiGieorgi Gerevini V, Dwivedi Y, Grayson D R, Impagnatiello F, Pandey G, Pesold C, Sharma R, Uzunov D, Costa E. Decrease in Reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder.  Arch Gen Psychiatry. 2000;  57 1061-1069
    CrossrefPubMedSearch in Google Scholar
  • 38 Fatemi S H, Earle J A, McMenomy T. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression.  Mol Psychiatry. 2000;  5 654-663
    CrossrefPubMedSearch in Google Scholar
  • 39 Block W, Bayer T A, Tepest R, Traber F, Rietschel M, Muller D J, Schulze T G, Honer W G, Maier W, Schild H H, Falkai P. Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study.  Neurosci Lett. 2000;  289 147-151
    CrossrefPubMedSearch in Google Scholar

Dr. med. Harald Scherk

Universitätskliniken des Saarlandes, Nervenklinik und Poliklinik - Psychiatrie und Psychotherapie

66421 Homburg

Email: harald.scherk@uniklinik-saarland.de